Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × OTHER_GOV × Imatinib Mesylate × Clear all

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

OTHER 4 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Breast Neoplasms 1

Interventions

Exercise 15 Standard of Care 9 Control Groups 8 Surgical Procedures, Operative 7 Radiotherapy, Intensity-Modulated 6 Radiotherapy 6 Endoscopic Mucosal Resection 6 Blood Specimen Collection 6 Drug Therapy 5 Metformin 4 Magnetic Resonance Spectroscopy 4 Laparoscopy 4 Indocyanine Green 4 Fluorouracil 4 Cisplatin 4 apatinib 3 anlotinib 3 Vitamin D 3 Therapeutics 3 Saline Solution 3 Proton Therapy 3 Preoperative Exercise 3 Methylene Blue 3 Mammography 3 Magnetic Resonance Imaging 3 Hematologic Tests 3 Diet 3 Cryotherapy 3 Congresses as Topic 3 pegylated granulocyte colony-stimulating factor 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05722795 2025-07-09

I-CONIC

Vastra Gotaland Region

Phase NA Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡